Markets
Elevance Health dives on outlook for post-Big Beautiful Bill world
(Samuel Corum/Getty Images)

ACA insurers drop as “beautiful” GOP law hits

Insurers that provide ACA coverage are getting battered after Elevance Health warned on the outlook for the market.

Health insurers that supply coverage to Affordable Care Act marketplaces, where some 24 million Americans get their health insurance, posted the ugliest losses in the S&P 500 on Friday, after one such insurer, Elevance Health, reported disappointing Q2 earnings and said it was raising premiums for such policies.

Elevance was the worst-performing stock in the S&P 500 for most of the first half of the day, before it was overtaken by Molina Healthcare, a similar insurer. Centene, another provider of government-related insurance, also tumbled.

Elevance’s Q2 numbers, released after the close of trading Thursday, weren’t horrible. They only just fell shy of Wall Street’s consensus expectation ($8.84 vs. $8.91). Sales of $49.42 billion were a bit better than expected.

But the company signaled growing uncertainty about its future, in part due to the “big, beautiful bill that passed the GOP-controlled Congress on a party-line vote and that President Trump signed into law early this month.

That bill lets the “enhanced subsides” for ACA marketplace buyers that began during the Covid crisis die at the end of the year.

According to the Congressional Budget Office, the loss of those enhanced subsidies is expected to knock roughly 4 million people off their ACA insurance in coming years.

This is a double whammy for insurers like Elevance. Obviously, it means fewer enrollees paying monthly premiums. But it also leaves insurers with a sicker client base and more expensive medical needs. (The people most likely to let their insurance lapse, even for reasons of affordability, tend to be those healthy enough to feel they can get away without coverage.)

“The biggest unknown for us right now is the policy uncertainties around the ultimate disposition of the enhanced subsidies in the individual ACA market,” Elevance CEO Gail Boudreaux told analysts after the company reported.

That said, the company is already raising the price of ACA individual insurance coverage to reflect the end of subsidies.

“Weve already repriced products for rising cost intensity,” Boudreaux said.

More Markets

See all Markets
markets
Rani Molla

Amazon just matched its longest losing streak in 20 years

Amazon shares marked their ninth straight day of losses — the company’s longest losing streak since 2006.

The milestone follows a fourth-quarter earnings miss, downbeat guidance, and a plan to spend a whopping $200 billion on capital expenditure this year.

Amazon is hoping that by spending big on AI infrastructure now, it will reap rewards from the technology later. Investors aren’t so sure.

Interestingly enough, the current situation sounds quite similar to the one Amazon was in two decades ago. Back then, Amazon endured a similar stretch as it was upping spending on tech and an online toy store — moves that would eat into its profits.

At the time, an asset manager told Bloomberg, “They want to capture as many eyeballs as they can on the Internet and be the go-to place on the Internet, but thats costing them earnings, at least right now.”

Sound familiar? In case you’re wondering, Amazon stock has risen 14,849% since that quote.

markets

Rivian is on pace for its best-ever trading day as analysts dig into Q4 results

EV maker Rivian is on track to log its best trading day on record Friday, as investors pour in following its fourth-quarter earnings report and 2026 guidance and analysts issue bullish appraisals of the shares.

Rivian shares are up more than 30% on Friday afternoon, easily surpassing its previous best trading day, which came in January 2025.

“We continue to remain confident in the long-term vision that RIVN is amid a massive transformation,” Wedbush Securities’ Dan Ives wrote in a fresh note on Friday. The firm maintained its $25 price target and “outperform” outlook and said that the launch of Rivian’s upcoming lower-cost SUV, the R2, is “crucial.”

Rivian received upgrades from Deutsche Bank (to “buy” from “hold”) and UBS (to “neutral” from “sell”) following its results.

On its Thursday earnings call, Rivian said it expects its delivery volume of its existing vehicle lineup to land “roughly in line with... 2025 total volumes.” Given the automaker’s full-year delivery guidance, that statement implies 2026 R2 deliveries to land between 20,000 and 25,000 units.

Self-driving features also appear to be boosting investor optimism. On Thursday’s earnings call, CEO RJ Scaringe said the company would enable “point-to-point” driving in its vehicles later this year. In a podcast interview released Thursday, Scaringe predicted that by 2030, it will be “inconceivable to buy a car and not expect it to drive itself.” Rivian is targeting “a little sooner than that,” he added.

Rivian shares are also likely benefiting from something of a snapback: before the release of its Q4 results, Rivian shares had been hammered recently, down 38% since their recent high in December.

“We continue to remain confident in the long-term vision that RIVN is amid a massive transformation,” Wedbush Securities’ Dan Ives wrote in a fresh note on Friday. The firm maintained its $25 price target and “outperform” outlook and said that the launch of Rivian’s upcoming lower-cost SUV, the R2, is “crucial.”

Rivian received upgrades from Deutsche Bank (to “buy” from “hold”) and UBS (to “neutral” from “sell”) following its results.

On its Thursday earnings call, Rivian said it expects its delivery volume of its existing vehicle lineup to land “roughly in line with... 2025 total volumes.” Given the automaker’s full-year delivery guidance, that statement implies 2026 R2 deliveries to land between 20,000 and 25,000 units.

Self-driving features also appear to be boosting investor optimism. On Thursday’s earnings call, CEO RJ Scaringe said the company would enable “point-to-point” driving in its vehicles later this year. In a podcast interview released Thursday, Scaringe predicted that by 2030, it will be “inconceivable to buy a car and not expect it to drive itself.” Rivian is targeting “a little sooner than that,” he added.

Rivian shares are also likely benefiting from something of a snapback: before the release of its Q4 results, Rivian shares had been hammered recently, down 38% since their recent high in December.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.